National Medical Products Administration: Fully committed to carrying out investigations and handling cases related to drug quality and safety.

On July 18, the National Medical Products Administration held a meeting to strengthen the investigation and handling of cases, with Xu Jinghe, member of the Party Group and deputy director of the National Medical Products Administration, attending and speaking. The meeting emphasized the extreme importance of ensuring drug safety, accurately grasping the current new situation and new requirements, implementing the "strictest measures", adhering to problem-oriented and results-oriented approaches, and making every effort to do well in the investigation and handling of drug quality and safety cases. It is necessary to conduct a thorough situation analysis and risk consultation, strengthen risk disposal, timely discover, control, and eliminate risks; effectively enhance the coordination, precision, and standardization of inspections to ensure that inspections are in place; rigorously crack down on illegal and criminal activities, strengthen the connection between law enforcement and discipline, and form a strong force to combat violations.